|
1
|
Carbone DP, Gandara DR, Antonia SJ,
Zielinski C and Paz-Ares L: Non-small-cell lung cancer: Role of the
immune system and potential for immunotherapy. J Thorac Oncol.
10:974–984. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Guillerey C and Smyth MJ: NK cells and
cancer immunoediting. Curr Top Microbiol Immunol. 395:115–145.
2016.PubMed/NCBI
|
|
3
|
Höglund P and Brodin P: Current
perspectives of natural killer cell education by MHC class I
molecules. Nat Rev Immunol. 10:724–734. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Parham P, Norman PJ, Abi-Rached L and
Guethlein LA: Human-specific evolution of killer cell
immunoglobulin-like receptor recognition of major
histocompatibility complex class I molecules. Philos Trans R Soc
Lond B Biol Sci. 367:800–811. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Parham P: MHC class I molecules and KIRs
in human history, health and survival. Nat Rev Immunol. 5:201–214.
2005. View
Article : Google Scholar : PubMed/NCBI
|
|
6
|
Campbell KS, Cella M, Carretero M,
Lopez-Botet M and Colonna M: Signaling through human killer cell
activating receptors triggers tyrosine phosphorylation of an
associated protein complex. Eur J Immunol. 28:599–609. 1998.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Katz G, Markel G, Mizrahi S, Arnon TI and
Mandelboim O: Recognition of HLA-Cw4 but not HLA-Cw6 by the NK cell
receptor killer cell Ig-like receptor two-domain short tail number
4. J Immunol. 166:7260–7267. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Benson DM Jr and Caligiuri MA: Killer
immunoglobulin-like receptors and tumor immunity. Cancer Immunol
Res. 2:99–104. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Al Omar S, Middleton D, Marshall E, Porter
D, Xinarianos G, Raji O, Field JK and Christmas SE: Associations
between genes for killer immunoglobulin-like receptors and their
ligands in patients with solid tumors. Hum Immunol. 71:976–981.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boyton RJ and Altmann DM: Natural killer
cells, killer immunoglobulin-like receptors and human leucocyte
antigen class I in disease. Clin Exp Immunol. 149:1–8. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Martin MP, Borecki IB, Zhang Z, Nguyen L,
Ma D, Gao X, Qi Y, Carrington M and Rader JS: HLA-Cw group 1
ligands for KIR increase susceptibility to invasive cervical
cancer. Immunogenetics. 62:761–765. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ferreiraa JA and Nyangomab SO: A
multivariate version of the Benjamini-Hochberg method. Journal of
Multivariate Analysis. 99:2108–2124. 2008. View Article : Google Scholar
|
|
13
|
Bao X, Hou L, Sun A, Qiu Q, Yuan X, Chen
M, Chen Z and He J: Distribution of killer cell immunoglobulin-like
receptor genes and 2DS4 alleles in the Chinese Han population. Hum
Immunol. 71:289–292. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yawata M, Yawata N, Draghi M, Little AM,
Partheniou F and Parham P: Roles for HLA and KIR polymorphisms in
natural killer cell repertoire selection and modulation of effector
function. J Exp Med. 203:633–645. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Díaz-Peña R, Vidal-Castiñeira JR, Mulero
J, Sánchez A, Queiro R and López-Larrea C: Activating killer
immunoglobulin-like receptors genes are associated with increased
susceptibility to ankylosing spondylitis. Clin Exp Immunol.
180:201–206. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
La Manna G, Corsini S, Iannelli S,
Cappuccilli ML, Comai G, Iorio M, Todeschini P, Carretta E, Scolari
MP, Bontadini A and Stefoni S: Influence of the immunogenetic KIR
and HLA systems on long-term renal transplant outcome. Ann
Transplant. 18:611–621. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Olvera A, Pérez-Álvarez S, Ibarrondo J,
Ganoza C, Lama JR, Lucchetti A, Cate S, Hildebrand W, Bernard N,
Gomez L, et al: The HLA-C*04: 01/KIR2DS4 gene combination and human
leukocyte antigen alleles with high population frequency drive rate
of HIV disease progression. AIDS. 29:507–517. 2015.PubMed/NCBI
|
|
18
|
Babor F, Manser AR, Fischer JC,
Scherenschlich N, Enczmann J, Chazara O, Moffett A, Borkhardt A,
Meisel R and Uhrberg M: KIR ligand C2 is associated with increased
susceptibility to childhood ALL and confers an elevated risk for
late relapse. Blood. 124:2248–2251. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
De Re V, Caggiari L, De Zorzi M, Talamini
R, Racanelli V, Da M, Buonadonna A, Zagonel V, Cecchin E, Innocenti
F and Toffoli G: Genetic diversity of the KIR/HLA system and
outcome of patients with metastatic colorectal cancer treated with
chemotherapy. PLoS One. 9:e849402014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wisniewski A, Jankowska R,
Passowicz-Muszyńska E, Wiśniewska E, Majorczyk E, Nowak I, Frydecka
I and Kuśnierczyk P: KIR2DL2/S2 and HLA-C C1C1 genotype is
associated with better response to treatment and prolonged survival
of patients with non-small cell lung cancer in a Polish Caucasian
population. Hum Immunol. 73:927–931. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Graef T, Moesta AK, Norman PJ, Abi-Rached
L, Vago L, Aguilar AM Older, Gleimer M, Hammond JA, Guethlein LA,
Bushnell DA, et al: KIR2DS4 is a product of gene conversion with
KIR3DL2 that introduced specificity for HLA-A*11 while diminishing
avidity for HLA-C. J Exp Med. 206:2557–2572. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Katz G, Gazit R, Arnon TI, Gonen-Gross T,
Tarcic G, Markel G, Gruda R, Achdout H, Drize O, Merims S and
Mandelboim O: MHC class I-independent recognition of NK-activating
receptor KIR2DS4. J Immunol. 173:1819–1825. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong HA, Paximadis M, Gray GE, Kuhn L and
Tiemessen CT: KIR2DS4 allelic variants: Differential effects on in
utero and intrapartum HIV-1 mother-to-child transmission. Clin
Immunol. 149:498–508. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Merino A, Malhotra R, Morton M, Mulenga J,
Allen S, Hunter E, Tang J and Kaslow RA: Impact of a functional
KIR2DS4 allele on heterosexual HIV-1 transmission among discordant
Zambian couples. J Infect Dis. 203:487–495. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Merino AM, Dugast AS, Wilson CM, Goepfert
PA, Alter G, Kaslow RA and Tang J: KIR2DS4 promotes HIV-1
pathogenesis: New evidence from analyses of immunogenetic data and
natural killer cell function. PLoS One. 9:e993532014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Pan N, Jiang W, Sun H, Miao F, Qiu J, Jin
H, Xu J, Shi Q, Xie W and Zhang J: KIR and HLA loci are associated
with hepatocellular carcinoma development in patients with
hepatitis B virus infection: A case-control study. PLoS One.
6:e256822011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Giebel S, Nowak I, Wojnar J,
Krawczyk-Kulis M, Holowiecki J, Kyrcz-Krzemien S and Kusnierczyk P:
Association of KIR2DS4 and its variant KIR1D with leukemia.
Leukemia. 22:2129–2131. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Giebel S, Boratyn-Nowicka A, Karabon L,
Jedynak A, Pamula-Pilat J, Tecza K, Kula D, Kowal M, Frydecka I and
Grzybowska E: Associations between genes for killer
immunoglobulin-like receptors and their ligands in patients with
epithelial ovarian cancer. Hum Immunol. 75:508–513. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cariani E, Pilli M, Zerbini A, Rota C,
Olivani A, Zanelli P, Zanetti A, Trenti T, Ferrari C and Missale G:
HLA and killer immunoglobulin-like receptor genes as outcome
predictors of hepatitis C virus-related hepatocellular carcinoma.
Clin Cancer Res. 19:5465–5473. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Purdy AK and Campbell KS: Natural killer
cells and cancer: Regulation by the killer cell Ig-like receptors
(KIR). Cancer Biol Ther. 8:2211–2220. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
de Smith AJ, Walsh KM, Ladner MB, Zhang S,
Xiao C, Cohen F, Moore TB, Chokkalingam AP, Metayer C, Buffler PA,
et al: The role of KIR genes and their cognate HLA class I ligands
in childhood acute lymphoblastic leukemia. Blood. 123:2497–2503.
2014. View Article : Google Scholar : PubMed/NCBI
|
